Predictive factors of peak radioactive iodine uptake moving forward in Graves' disease patients receiving iodine-131 therapy

被引:0
|
作者
Zhang, R. [1 ]
Qin, L. [1 ]
Wang, J. [1 ]
机构
[1] Tianjin First Cent Hosp, Dept Nucl Med, Tianjin, Peoples R China
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
P613
引用
收藏
页码:S535 / S535
页数:1
相关论文
共 50 条
  • [1] Predictive factors of repeat therapy in patients receiving iodine-131 for Graves' disease
    Zhang, Ruiguo
    Qin, Lan
    Ren, Zhong
    Wang, Junqi
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54
  • [2] Predictive factors for the outcomes of Graves' disease patients with radioactive iodine (131I) treatment
    Xing, Yu-Zhuo
    Zhang, Kun
    Jin, Gang
    BIOSCIENCE REPORTS, 2020, 40
  • [3] Transient hypothyroidism after iodine-131 therapy for Graves' disease
    Gómez, N
    Gómez, JM
    Villabona, C
    Soler, J
    CLINICAL ENDOCRINOLOGY, 1998, 48 (04) : 526 - 527
  • [4] Influence of an additional application of iodine-127 on the pharmacokinetics of radioactive iodine-131 during a radioiodine therapy in patients with Graves' disease.
    Moka, D
    Reinholz, U
    Eschner, W
    Wellner, U
    Schicha, H
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 332P - 333P
  • [5] Predictive factors for early hypothyroidism following the radioactive iodine therapy in Graves’ disease patients
    Rui-Ting Hu
    De-Shan Liu
    Bin Li
    BMC Endocrine Disorders, 20
  • [6] Predictive factors for early hypothyroidism following the radioactive iodine therapy in Graves' disease patients
    Hu, Rui-Ting
    Liu, De-Shan
    Li, Bin
    BMC ENDOCRINE DISORDERS, 2020, 20 (01)
  • [7] Acute promyelocytic leukemia after iodine-131 therapy for Graves' disease
    Kolade, VO
    Bosinski, TJ
    Ruffy, EL
    PHARMACOTHERAPY, 2005, 25 (07): : 1017 - 1020
  • [8] Hypothyroidism after iodine-131 or surgical therapy for Graves' disease hyperthyroidism
    Gómez, JM
    Gómez, N
    Amat, M
    Biondo, S
    Rafecas, A
    Jaurrieta, E
    Soler, J
    ANNALES D ENDOCRINOLOGIE, 2000, 61 (03) : 184 - 191
  • [9] Iodine-131 therapy alters the immune/inflammatory responses in the thyroids of patients with Graves' disease
    Du, Wenhua
    Dong, Qingyu
    Lu, Xiaoting
    Liu, Xiaomeng
    Wang, Yueli
    Li, Wenxia
    Pan, Zhenyu
    Gong, Qian
    Liang, Cuige
    Gao, Guanqi
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (03) : 1155 - 1159
  • [10] Predictive Factors of Outcomes in Personalized Radioactive Iodine (131I) Treatment for Graves' Disease
    Liu, Min
    Jing, Danqing
    Hu, Jingsheng
    Yin, Shinan
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2014, 348 (04): : 288 - 293